SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

CEL-SCI to launch FDA registration-enabling Phase 3 Confirmatory study

CEL-SCI Corporation...

CVM

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.